Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Outcomes of Eyes with Retinoschisis-Related Retinal Detachment
Author Affiliations & Notes
  • Bita Momenaei
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Asad Farooq Durrani
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Kristine Wang
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Jason Hsu
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Bita Momenaei None; Asad Durrani None; Kristine Wang None; Jason Hsu consultant for IvericBio and Gyroscope Therapeutics, Code C (Consultant/Contractor), grant support from IvericBio, Aldeyra Therapeutics, and Genentech/Roche, Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 922. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bita Momenaei, Asad Farooq Durrani, Kristine Wang, Jason Hsu; Outcomes of Eyes with Retinoschisis-Related Retinal Detachment. Invest. Ophthalmol. Vis. Sci. 2024;65(7):922.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate visual and anatomic outcomes in patients who have undergone primary interventions for schisis-detachment.

Methods : A retrospective review was conducted on eyes that underwent a procedure for schisis-related retinal detachment (RD) between January 2015 and November 2022. Eyes with X-linked retinoschisis, isolated macular schisis, RD unrelated to schisis, and <6 months of follow-up were excluded. Primary outcome measures were the incidence of redetachment following the initial intervention, as well as visual and anatomic outcomes at 6 months and the final visit.

Results : After reviewing 174 eyes, 67 eyes of 67 patients met the inclusion criteria. The mean (standard deviation, SD) follow-up duration was 38.3 (24.3) months. Macular involvement was observed in 27 eyes (40.3%), and proliferative vitreoretinopathy (PVR) was present in 8 eyes (11.9%) at the time of primary RD. The initial repair methods included laser retinopexy in 23 eyes (34.3%), vitrectomy in 23 eyes (34.3%), combined vitrectomy and buckle in 13 eyes (19.4%), and buckle alone in 8 eyes (11.9%). The initial procedure failed in 7 eyes (30.4%) that underwent laser and 9 eyes (20.5%) that underwent surgery (P=0.381) after a median time (interquartile range, IQR) of 70 days (14-623) and 65 days (29-187), respectively. Single surgery anatomic success (SSAS) for RD repair was achieved in 81.8% of eyes (36/44) at 3 months. The anatomic success rate for reattachment was 91.3% at 6 month and 95.7% at the final visit in the laser group, and 97.7% at 6 months and at the final visit in the surgical group, with 8 eyes and 5 eyes remaining silicone oil-filled at these visits. The mean (SD) logarithm of the minimal angle of resolution (logMAR) visual acuity at the 6 month and final visit was 0.52 (0.55, Snellen equivalent: 20/66) and 0.37 (0.54, 20/47), showing no significant change compared to vision at the time of RD diagnosis (0.46 (0.66), 20/58) (P=0.844 and 0.276).

Conclusions : The treatment of schisis-detachment appears to lead to generally acceptable anatomical outcomes with preservation of vision. However, the relatively high redetachment rate suggests that these types of RDs may be more difficult to treat than non-schisis related rhegmatogenous RDs.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×